Objective: 1) Describe a safe, efficient, and effective pathway for the development of transoral robotic surgical skills in otorhinolaryngology residency training, and 2) Report initial results of resident experience in the training modules.
Objective: 1) Determine if an association exists between age and overall survival (OS) and progression-free survival (PFS) in induction chemotherapy (IC) for head and neck cancer (HNC). 2) Compare age-specific response to 2 different chemotherapy regimen in HNC.
Method: A total of 501 patients enrolled on TAX 324 study (1999 to 2003) were evaluated. Patients had nonmetastatic, unresectable stage III/IV HNC. A total of 255 patients received IC with docetaxel, cisplatin, 5FU (TPF), and 246 received cisplatin, 5 fluorouracil (PF). The cohort was split into 2 groups; 55 years.
Results:
Fisher exact test and general linear model approach compared clinical and demographic characteristics between treatment arms. Kaplan-Meir method estimated OS and PFS.
Stepwise Cox regression modeled OS and PFS functions. A total of 249 patients were 55 years, 127 were assigned to TPF arm and 125 to PF arm, Total failures reached statistical significance between the 2 arms; there were 50 total failures in the TPF arm and 58 in the PF arm (0.65, 0.42-0.98; 0.04).
Conclusion:
Our study contradicts the small amount of published evidence on age-specific responses to chemotherapy regimen in breast, prostate, and lung cancer. It is the first study of its kind evaluating the role of age in overall survival in chemotherapy in HNC.
Head and Neck Surgery Impact of Regulatory T Cells in Oropharyngeal Cancer
Jan Boucek, MD (presenter); Blanka Rihova; Jaroslav Betka; Tomas Eckschlager; Michal Zabrodsky, MD; Jan Betka, MD, PhD
Objective: Oropharyngeal cancer is the most frequent type of malignancy in the head and neck area. Regulatory T cells (Treg, CD4+CD25+Foxp3+) and Th17 cells were described as critical factors for regulation or inhibition of effective anti-cancer immune response and, consequently, prognosis and survival.
Method:
We examined Treg and Th17 from periphery blood and tumor samples of patients with oropharyngeal cancer before the start of anti-tumor therapy. We particularly focused on lymphocytes subpopulations (CD3+, CD3-CD16+CD56+, CD4+, CD8+, CD19+, CD4+CD45RA+, CD3+CD4+CD25+, CD161+CD4+ a CD161+CD8+) and tumor markers (SCC, CEA, AAT, Cyfra 21-1).
Results:
In comparison with control group (nononcologic surgery), the Treg population in the peripheral blood of the patients with oropharyngeal cancer was 1.6-fold higher.
Infiltration of Treg in specimens from primary tumors and metastatic neck lymph nodes was higher (8.7% and 9.6%) in comparison with oropharyngeal tissue and neck lymph nodes without tumor or metastatic extension (3.12% and 3.3%, both p+CD161+cells and 12.8% CD8+CD161+ cells, and in tumor tissue, 1.66% CD4+CD161+ cells and 3.9% CD8+CD161+ cells. Level of tumor marker CEA correlated with higher T stadium (T3+4, t-test, P < .005).
Conclusion:
We can conclude that regulatory T cells and Th17 generally represent a highly important factor in the progression of many types of malignancies and our data indicated their particular importance for oropharyngeal cancer.
Head and Neck Surgery IMRTSIB and Concurrent CT for LAHNC: Toxicity and Quality of Life
Alessia Piccinini (presenter); Andrea Rocchi; Giuseppina De Marco; Laura Marra; Angelo Ghidini, MD; Gabriele Molteni, MD; Livio Presutti, MD Objective: Evaluate the acute toxicity of postoperative radiotherapy with intensity modulated simultaneous integrated boost (IMRT-SIB) and the impact of this treatment on quality of life for patients with head and neck cancer locally advanced (LAHNC). Results: Median follow-up was 10 months (range, 2-30 months). Acute mucositis ≥ G2 occurred in 18 patients. Acute reactions ≥ G2 on salivary glands in 15 patients. Acute reaction ≥ G3 appeared in 4 patients on mucosae and in 5 on pharynx. At time of analysis 18 patients were free from locoregional recurrence.
Method:
Conclusion: IMRT-SIB and concurrent cisplatin is feasible and well tolerated in LAHNC and is not correlated with a decrease in healthy functioning, global health status, or subjective evaluation of level of illness.
